Compare VERX & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VERX | ATRC |
|---|---|---|
| Founded | 1978 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2020 | 2005 |
| Metric | VERX | ATRC |
|---|---|---|
| Price | $12.73 | $44.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 7 |
| Target Price | $24.25 | ★ $51.17 |
| AVG Volume (30 Days) | ★ 2.6M | 877.7K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 74.74 |
| EPS | N/A | ★ 0.18 |
| Revenue | ★ $748,444,000.00 | $201,630,000.00 |
| Revenue This Year | $12.78 | $15.27 |
| Revenue Next Year | $11.61 | $12.21 |
| P/E Ratio | $302.25 | ★ $241.61 |
| Revenue Growth | 12.25 | ★ 15.40 |
| 52 Week Low | $10.21 | $25.36 |
| 52 Week High | $26.63 | $44.38 |
| Indicator | VERX | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 52.90 | 75.95 |
| Support Level | $12.16 | $39.40 |
| Resistance Level | $13.36 | N/A |
| Average True Range (ATR) | 0.67 | 1.67 |
| MACD | 0.05 | 0.30 |
| Stochastic Oscillator | 60.45 | 96.40 |
Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. It provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting, among others. The company derives revenue from software subscriptions.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.